Oncolytics Biotech (ONCY) Restructuring Costs (2024 - 2025)
Oncolytics Biotech (ONCY) posted quarterly Restructuring Costs of $88.65 for Q3 2025, up 4.25% year-over-year from $85.03 in Q3 2024, and up 4.25% quarter-over-quarter from $85.03 in Q3 2024.
Oncolytics Biotech (ONCY) Restructuring Costs (2024 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Restructuring Costs for 2 consecutive years, with $88.65 the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Oncolytics Biotech | 99.00 Mn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 88.65 |
| Sep 30, 2024 | 85.03 |